J. Husmark et al., N-cadherin-mediated adhesion and aberrant catenin expression in anaplasticthyroid-carcinoma cell lines, INT J CANC, 83(5), 1999, pp. 692-699
The role of cadherins and catenins in the progression of thyroid carcinoma
is unclear. We have investigated as beta- and gamma-catenins and p120(ctn)
in relation to the expression of cadherins in human anaplastic thyroid-carc
inoma cell lines (HTh7, HTh74, C643 and SW 1736) with Western blotting and
immunofluorescence. E-cadherin was lacking except in SW1736, which consiste
d of E-cadherin-positive (approx. 5%) and -negative cells. The alpha- and b
eta-catenin levels were similar to those of primary cultured non-neoplastic
(E-cadherin-positive) human thyrocytes. In contrast, the expression of gam
ma-catenin was low and variable, correlating with the different levels of c
ytokeratin in the same cells (HTh74 > SW1736 > C643 > HTh7). p120(ctn) reso
lved as a doublet in Western blots; the approximately 100-kDa band also fou
nd in nonneoplastic epithelial cells was reduced whereas the approximately
115-kDa band, corresponding to the fibroblast-type isoform of p 120(ctn), w
as neo-expressed. A DNA-demethylating agent, 5-aza-2'-deoxycytidine, up-reg
ulated E-cadherin in SW1736 and gamma-catenin in SWI736 and C643, whereas t
he other cell lines were unresponsive; other catenins were not affected. Th
e catenins were generally distributed along the cell borders. Immunostainin
g, cell-surface biotinylation and co-immunoprecipitation revealed that all
cell lines expressed N-cadherin in connection with beta-catenin at the plas
ma membrane, Incubation with an N-cadherin antibody disrupted cell-cell adh
esion. We conclude that E-cadherin-negative anaplastic thyroid-carcinoma ce
ll lines display functional N-cadherin/beta-catenin complexes, partial or c
omplete loss of gamma-catenin, and isoform shift: of p120(ctn). The unequal
expression of E-cadherin and gamma-catenin and the variable response to DN
A de-methylation suggest that anaplastic thyroid carcinoma is not a uniform
entity. (C) 1999 Wiley-liss, Inc.